AtaiBeckley (NASDAQ: ATAI) stock jumps on Lilly deal as market discounts milestones
NEW YORK, July 16, 2026, 10:05 a.m. EDT U.S. cash markets were open. AtaiBeckley traded near $7.04, up about 31%. Lilly’s $6.75 cash bid leaves roughly $0.29 of preliminary implied CVR value…
Read the full articleYou might also wanna read
Iovance shares surge as attention shifts to Amtagvi’s second-half sales target
ts2.tech·22h ago
GSK plc (LON:GSK) drops after cough medicine blow wipes £2.4 billion off market value
ts2.tech·1d ago
Eli Lilly (NYSE:LLY) Shares Rise After Atai Partnership Could Unlock $1 Billion in Milestones
ts2.tech·1d ago
Pfizer (NYSE:PFE) scores FDA approval but Wall Street reaction muted
ts2.tech·5d ago
National Australia Bank (ASX:NAB) advances as cooling price pressure supports key profit driver
ts2.tech·10h ago
Macquarie Group (ASX:MQG) deposit growth highlights focus on margins near 52-week top
ts2.tech·10h ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.